Cor Vasa 2010, 52(7-8):399-402 | DOI: 10.33678/cor.2010.108
The genetics of cardiomyopathies
- Kardiologické oddělení, Kardiovaskulární centrum, Fakultní nemocnice Motol, Praha, Česká republika
Cardiomyopathies make up a heterogeneous group of diseases with structural or functional myocardial impairment in the absence of an ischemic or hemodynamic insult capable of inducing this impairment. As a considerable proportion of cardiomyopathies is genetically mediated, they tend to occur more often in family members. The heritability of cardiomyopathy exhibits large genotype and phenotype variability and often incomplete penetrance. New concepts in the field of genetics of cardiomyopathies have helped to partly clarify the etiopathogenesis of these diseases and have become part of new classification systems of myocardial diseases. The most important clinical application of genetics in patients with cardiomyopathies is screening of their relatives. Future challenges of genetic research include more accurate risk stratification of patients and wider availability of routine DNA-based diagnosis.
Keywords: Cardiomyopathies; Hereditable diseases; Genetic testing
Published: July 1, 2010 Show citation
References
- Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies. An American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-1816.
Go to original source...
Go to PubMed...
- Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29:270-276.
Go to original source...
Go to PubMed...
- Maron BJ. The 2006 American Heart Association Classification of cardiomyopathies is the gold standard. Circ Heart Fail 2008;1:72-76.
Go to original source...
Go to PubMed...
- Elliott P. The 2006 American Heart Association Classification of cardiomyopathies is not the gold standard. Circ Heart Fail 2008;1:77-80.
Go to original source...
Go to PubMed...
- Ashrafian H, Watkins H. Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J Am Coll Cardiol 2007;49:1251-1264.
Go to original source...
Go to PubMed...
- Perrot A, Dietz R, Osterziel KJ. Is there a common genetic basis for all familial cardiomyopathies? Eur J Heart Fail 2007;9:4-6.
Go to original source...
Go to PubMed...
- Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 2008;5:158-168.
Go to original source...
Go to PubMed...
- Bos JM, Towbin JA, Ackermann MJ. Diagnostic, prognostic and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:201-211.
Go to original source...
Go to PubMed...
- Binder J, Ommen SR, Gersh BJ, et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 2006;81:459-467.
Go to original source...
Go to PubMed...
- Vatta M, Marcus F, Towbin JA. Arrhythmogenic right ventricular cardiomyopathy: a 'final common pathway' that defines clinical phenotype. Eur Heart J 2007;28:529-530.
Go to original source...
Go to PubMed...
- Protonotarios N, Tsatsopoulou A. Naxos disease. Indian Pacing Electrophysiol J 2005;5:76-80.